Valneva SE (INRLF)
OTCMKTS · Delayed Price · Currency is USD
4.750
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Valneva SE Employees
Valneva SE had 700 employees as of June 30, 2025.
Employees
700
Change
n/a
Growth
n/a
Revenue / Employee
$296,059
Profits / Employee
-$168,112
Market Cap
837.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 700 | - | - |
| Dec 31, 2024 | 713 | 37 | 5.47% |
| Dec 31, 2023 | 676 | -43 | -5.98% |
| Dec 31, 2022 | 719 | -43 | -5.64% |
| Dec 31, 2021 | 762 | 262 | 52.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
Valneva SE News
- 6 days ago - VALNEVA Declaration of shares and voting rights: January 31, 2026 - GlobeNewsWire
- 9 days ago - Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 23 days ago - Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 23 days ago - Valneva Withdraws Chikungunya Vaccine IXCHIQ Applications In U.S. Amid FDA Suspension - Nasdaq
- 23 days ago - Valneva (VALN) Withdraws Chikungunya Vaccine Applications in the U.S. - GuruFocus
- 23 days ago - Valneva withdraws application for standard US approval of its chikungunya shot - Reuters
- 23 days ago - Valneva Provides Update on Chikungunya Vaccine IXCHIQ® - GlobeNewsWire
- 4 weeks ago - Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference - GlobeNewsWire